/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Neoscope

Topic

Latest Stories

Monkey Pigs
12.6.19, 12:55 PM EST on neoscope
First-Ever "Pig-Monkey Chimeras" Born in Chinese Lab
Door-to-Door Vacc...
12.5.19, 3:15 PM EST on neoscope
Nation's Entire Gov Shuts Down to Focus on Measles Outbreak
Brain Control 101
Updated 12.5.19, 2:36 PM EST on neoscope
MIT Says New Technique Lets You Hack Your Own Brain Waves
Genetic Screening
12.5.19, 2:02 PM EST on neoscope
Chinese 23andMe Knockoff Gives Different Results From 23andMe
Red Flags
12.5.19, 1:00 PM EST on neoscope
Gene-Hacking Company Says It Can Slow Your Aging for $1 Million
Shady Study
Updated 12.4.19, 4:06 PM EST on neoscope
Experts Horrified by Leaked CRISPR Baby Study
Puff Balls
12.4.19, 12:01 PM EST on neoscope
New Analysis: Marijuana Seems to Be Linked to Testicular Cancer
Genetic Surveillance
12.4.19, 11:22 AM EST on neoscope
China Is Using Blood From Minorities For Genetic Research
Best Breasts
Updated 12.3.19, 4:15 PM EST on neoscope
Surgeons Use Eye-Tracking Tech to Find the "Perfect Boob"
Brain Chips
12.3.19, 2:30 PM EST on neoscope
Scientists Finally Build Artificial Brain Cells
Master Manipulators
12.2.19, 2:29 PM EST on neoscope
Drug Rep Exposes How Big Pharma Pushed Opioids
Special K
11.27.19, 2:09 PM EST on neoscope
Study: Want to Stop Drinking So Much? Do Ketamine Once.
  • Previous
  • 1
  • ...
  • 200
  • 201
  • 202
  • ...
  • 213
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.